Erythroblastosis Fetalis

STILLBIRTH remains a major problem in erythroblastosis fetalis caused by Rh incompatibility, since about 20 per cent of the fetuses in these cases die in utero. The ultimate failure of all preventive methods that have been enthusiastically advocated in the past1 2 3 4 illustrates the difficulty of interpreting the results of therapy in this condition. This difficulty arises from two principal factors: the great variability and unpredictability of erythroblastosis, and the fact that any method of treatment tends to result in a selected series of cases that may not be comparable with a previous, untreated series.This study presents a nine-year survey . . .